Andrea Sartore‐Bianchi
University of Milan(IT)University of Pavia(IT)Ospedale Maggiore(IT)Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda(IT)NeuroMetrix (United States)(US)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, Lung Cancer Treatments and Mutations, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies(2014)5,005 cited
- → Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis(2010)2,133 cited
- → Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer(2012)1,867 cited
- → Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer(2008)1,589 cited
- → Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients(2015)1,079 cited
- → Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial